CN101094863A - 用作细胞内转运目标分子用载体的毛若考辛衍生多肽 - Google Patents

用作细胞内转运目标分子用载体的毛若考辛衍生多肽 Download PDF

Info

Publication number
CN101094863A
CN101094863A CNA2005800457088A CN200580045708A CN101094863A CN 101094863 A CN101094863 A CN 101094863A CN A2005800457088 A CNA2005800457088 A CN A2005800457088A CN 200580045708 A CN200580045708 A CN 200580045708A CN 101094863 A CN101094863 A CN 101094863A
Authority
CN
China
Prior art keywords
purposes
represent
cell
sequence
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800457088A
Other languages
English (en)
Chinese (zh)
Inventor
米歇尔·朗沙
米歇尔·德瓦特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
National Institutes of Health NIH
Original Assignee
Commissariat a lEnergie Atomique CEA
National Institutes of Health NIH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA, National Institutes of Health NIH filed Critical Commissariat a lEnergie Atomique CEA
Publication of CN101094863A publication Critical patent/CN101094863A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43522—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from scorpions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CNA2005800457088A 2004-11-12 2005-11-14 用作细胞内转运目标分子用载体的毛若考辛衍生多肽 Pending CN101094863A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0412045 2004-11-12
FR0412045A FR2877946B1 (fr) 2004-11-12 2004-11-12 Peptides derives de la maurocalcine utilisables comme vecteurs pour l'adressage intracellulaire de molecules d'interet

Publications (1)

Publication Number Publication Date
CN101094863A true CN101094863A (zh) 2007-12-26

Family

ID=34953760

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800457088A Pending CN101094863A (zh) 2004-11-12 2005-11-14 用作细胞内转运目标分子用载体的毛若考辛衍生多肽

Country Status (9)

Country Link
US (1) US8207293B2 (enExample)
EP (1) EP1814905B1 (enExample)
JP (1) JP5416901B2 (enExample)
CN (1) CN101094863A (enExample)
AU (1) AU2005303623A1 (enExample)
CA (1) CA2586811A1 (enExample)
FR (1) FR2877946B1 (enExample)
IL (1) IL183022A0 (enExample)
WO (1) WO2006051224A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105087492A (zh) * 2015-07-16 2015-11-25 中国人民解放军军事医学科学院放射与辐射医学研究所 培养原代海马神经元的方法

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2537858A1 (en) 2011-06-20 2012-12-26 Commissariat à l'Énergie Atomique et aux Énergies Alternatives Small efficient cell penetrating peptides derived from the scorpion toxin maurocalcine
WO2014141124A1 (en) 2013-03-13 2014-09-18 Institut National De La Sante Et De La Recherche Medicale Erk-pathway activating compound for preventing or treating leptin resistance
SG11201507142QA (en) 2013-03-15 2015-10-29 Techulon Inc Antisense molecules for treatment of staphylococcus aureus infection
WO2014144423A2 (en) 2013-03-15 2014-09-18 Techulon Inc. Antisense molecules for treatment of staphylococcus aureus infection
SMT201800589T1 (it) * 2013-06-12 2019-01-11 Pharis Biotec Gmbh Peptidi con attivita' antagoniste contro cxcr4 naturale
US11559580B1 (en) 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof
JP6966424B2 (ja) 2015-09-09 2021-11-17 フレッド ハッチンソン キャンサー リサーチ センター 軟骨ホーミングペプチド
WO2017100700A2 (en) * 2015-12-11 2017-06-15 Fred Hutchinson Cancer Research Center Peptides for renal therapy
CA3049262A1 (en) 2017-01-18 2018-07-26 Fred Hutchinson Cancer Research Center Peptide compositions and methods of use thereof for disrupting tead interactions
AU2018236465A1 (en) 2017-03-16 2019-08-22 Blaze Bioscience, Inc. Cartilage-homing peptide conjugates and methods of use thereof
CA3064436A1 (en) 2017-06-15 2018-12-20 Blaze Bioscience, Inc. Renal-homing peptide conjugates and methods of use thereof
JP7386161B2 (ja) 2017-12-19 2023-11-24 ブレイズ バイオサイエンス， インコーポレイテッド 腫瘍ホーミング及び細胞透過性ペプチド免疫抗がん剤複合体、ならびにそれらの使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051429A (en) * 1995-06-07 2000-04-18 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
FR2739621B1 (fr) 1995-10-05 1997-12-05 Centre Nat Rech Scient Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives
AU768673B2 (en) 1998-09-15 2003-12-18 Nizo Food Research Process for producing peptides from biological fluids and peptides obtainable by said process
GB0005124D0 (en) * 2000-03-03 2000-04-26 Cellpep Sa Maurocalcin,analogues thereof and their therapeutical uses
US7781488B2 (en) * 2002-06-10 2010-08-24 Amylin Pharmaceuticals, Inc. Post-cleavage sulfur deprotection for convergent protein synthesis by chemical ligation
SE0201863D0 (en) 2002-06-18 2002-06-18 Cepep Ab Cell penetrating peptides

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105087492A (zh) * 2015-07-16 2015-11-25 中国人民解放军军事医学科学院放射与辐射医学研究所 培养原代海马神经元的方法

Also Published As

Publication number Publication date
EP1814905A1 (fr) 2007-08-08
AU2005303623A1 (en) 2006-05-18
WO2006051224A1 (fr) 2006-05-18
EP1814905B1 (fr) 2013-04-17
FR2877946A1 (fr) 2006-05-19
JP2008519592A (ja) 2008-06-12
IL183022A0 (en) 2007-09-20
CA2586811A1 (fr) 2006-05-18
US20090142266A1 (en) 2009-06-04
US8207293B2 (en) 2012-06-26
JP5416901B2 (ja) 2014-02-12
FR2877946B1 (fr) 2011-02-11

Similar Documents

Publication Publication Date Title
Wagstaff et al. Protein transduction: cell penetrating peptides and their therapeutic applications
JP5802250B2 (ja) 融合ペプチド治療用組成物
Magzoub et al. Cell-penetrating peptides: small from inception to application
Gupta et al. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides
Futaki Membrane-permeable arginine-rich peptides and the translocation mechanisms
EP2928907B1 (en) Cell penetrating peptides for intracellular delivery of molecules
KR100608558B1 (ko) 세포질 잔류성 세포막 투과 펩타이드 및 이의 용도
JP5858285B2 (ja) キャリアペプチドフラグメント及びその利用
Beerens et al. Protein transduction domains and their utility in gene therapy
CN104039811B (zh) 具有改善的细胞渗透性的新的大分子转导结构域的研发及其使用方法
JP2011511641A (ja) システインに富む新規な細胞膜透過性ペプチドの同定
Hudecz et al. Medium‐sized peptides as built in carriers for biologically active compounds
CN101094863A (zh) 用作细胞内转运目标分子用载体的毛若考辛衍生多肽
US9439975B2 (en) Small efficient cell penetrating peptides derived from the scorpion toxin maurocalcine
JP7456676B2 (ja) 新規な細胞透過性ペプチド及びその用途
KR100935030B1 (ko) 새로운 세포투과성 펩타이드 및 이를 이용한 생물학적 활성물질의 전달 방법
KR102398339B1 (ko) 일산화질소 전달용 융합 펩타이드 및 이의 용도
Kobayashi et al. Nucleolar localization signals of LIM kinase 2 function as a cell-penetrating peptide
Fuchs et al. A closer look at protein transduction domains as a tool in drug delivery
KR101775625B1 (ko) 혈장 내에서 안정성이 증가된 신규한 세포투과성 펩타이드 및 이것의 용도
KR20230006405A (ko) 신규한 세포 투과성 펩타이드 및 이의 용도
Beerens Intercellular spread of the transgene product to improve the efficiency of cancer gene therapy
KR100996953B1 (ko) 세포 내로 나노입자를 전달하는 방법 및 이를 위한 펩타이드
Wagstaff et al. Protein Transduction: Cell Penetrating Peptides and Their Therapeutic Applications
Pattabiraman The design, synthesis and evaluation of guanidine-based molecular transporters

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20071226